VEDRAX SAS
Vedrax offers advanced biostatistics and AI-powered solutions for the pharmaceutical lifecycle, from clinical trial design to post-market surveillance. They combine cutting-edge statistics, AI, and cloud technology to make drug development faster, safer, and smarter. Their services include clinical trial design and analysis, bioequivalence studies, PK/PD modeling, population analysis, stability studies, manufacturing analytics, regulatory submissions, and post-market surveillance, with a focus on adaptive trial designs, power & sample size calculation, and endpoint optimization. They also leverage blockchain for audit and integrity. Vedrax aims to cut costs, speed up decisions, reduce patient exposure, and increase success rates while maintaining regulatory confidence.
VEDRAX SAS
Vedrax offers advanced biostatistics and AI-powered solutions for the pharmaceutical lifecycle, from clinical trial design to post-market surveillance. They combine cutting-edge statistics, AI, and cloud technology to make drug development faster, safer, and smarter. Their services include clinical trial design and analysis, bioequivalence studies, PK/PD modeling, population analysis, stability studies, manufacturing analytics, regulatory submissions, and post-market surveillance, with a focus on adaptive trial designs, power & sample size calculation, and endpoint optimization. They also leverage blockchain for audit and integrity. Vedrax aims to cut costs, speed up decisions, reduce patient exposure, and increase success rates while maintaining regulatory confidence.